Is Kezar Life Sciences Inc (KZR) undervalued? · $53.9M cap
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
This page asks whether Kezar Life Sciences Inc (KZR) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
KZR currently screens at market cap $53.9M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new KZR 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare KZR to the stock page model before you treat a low multiple as a gift.
Not investment advice.